Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa

MLA

Fotiadou C, et al. “Spotlight on Adalimumab in the Treatment of Active Moderate-to-Severe Hidradenitis Suppurativa.” Clinical, Cosmetic and Investigational Dermatology, vol. ume 9, Oct. 2016, pp. 367–72. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.6542fe4fa874d54b16b9dad87b39cb8&authtype=sso&custid=ns315887.

APA

Fotiadou C, Vakirlis E, & Ioannides D. (2016). Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa. Clinical, Cosmetic and Investigational Dermatology, ume 9, 367–372.

Chicago

Fotiadou C, Vakirlis E, and Ioannides D. 2016. “Spotlight on Adalimumab in the Treatment of Active Moderate-to-Severe Hidradenitis Suppurativa.” Clinical, Cosmetic and Investigational Dermatology ume 9 (October): 367–72. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.6542fe4fa874d54b16b9dad87b39cb8&authtype=sso&custid=ns315887.